|
Press Releases
All 2010 Releases
 |
Vyteris to Present at Rodman & Renshaw Annual Global Investment Conference
Sep 7, 2010
|
8.5 KB |
|
| |
FAIR LAWN, NJ, Sep 07, 2010 (MARKETWIRE via COMTEX News Network) -- Vyteris, Inc. (OTCBB: VYTR), manufacturer of the first FDA-approved active patch transdermal drug delivery system and a leader in active transdermal drug delivery technology, today announced that President and Chief Executive Officer Haro Hartounian, Ph.D. will present at the Rodma...
|
|
Vyteris and Georgia Tech Enter Into Exclusive Agreement for Transdermal Drug Delivery Technologies
Aug 24, 2010
|
9.9 KB |
|
| |
FAIR LAWN, NJ, Aug 24, 2010 (MARKETWIRE via COMTEX News Network) -- Vyteris, Inc. (OTCBB: VYTR), developer of the first FDA-approved active transdermal patch and a leader in alternative drug delivery technology, today announced an agreement with the Georgia Tech Research Corporation of the Georgia Institute of Technology (Georgia Tech) granting Vyt...
|
|
Vyteris Announces Positive Results From Phase II Clinical Trial of Transdermal Patch for Female Infertility
Aug 10, 2010
|
10.1 KB |
|
| |
FAIR LAWN, NJ, Aug 10, 2010 (MARKETWIRE via COMTEX News Network) -- Vyteris, Inc. (OTCBB: VYTR), developer of the first FDA-approved active transdermal patch and a leader in alternative drug delivery technology, today announced positive results from a Phase II clinical trial evaluating the safety and efficacy of a pulsatile delivery system for the ...
|
|
Vyteris Expands Scientific Advisory Board With Four New Appointments
Jul 13, 2010
|
12.5 KB |
|
| |
FAIR LAWN, NJ, Jul 13, 2010 (MARKETWIRE via COMTEX News Network) -- Vyteris, Inc. (OTCBB: VYTR), manufacturer of the first FDA-approved active patch transdermal drug delivery system, and a leader in active transdermal drug delivery technology, today announced the appointment of four new members to its Scientific Advisory Board (SAB). The new appoin...
|
|
Vyteris to Present at OneMedForum New York 2010
Jun 25, 2010
|
8.5 KB |
|
| |
FAIR LAWN, NJ, Jun 25, 2010 (MARKETWIRE via COMTEX News Network) -- Vyteris, Inc. (OTCBB: VYTR), manufacturer of the first FDA-approved active patch transdermal drug delivery system and a leader in active transdermal drug delivery technology, today announced that President and Chief Executive Officer Haro Hartounian, Ph.D. will present at OneMedFor...
|
|
Vyteris Appoints Joel Kanter to the Board of Directors
Mar 23, 2010
|
9.3 KB |
|
| |
FAIR LAWN, NJ, Mar 23, 2010 (MARKETWIRE via COMTEX News Network) -- Vyteris, Inc. (OTCBB: VYTR), developer of the first FDA-approved active transdermal drug delivery system, announced today the appointment of Joel Kanter to the Company's Board of Directors. Mr. Kanter currently serves as the President of Windy City Inc., an investment management fi...
|
|
Vyteris Appoints Dr. Eugene A. Bauer as Chairman of the Board
Feb 17, 2010
|
9.3 KB |
|
| |
FAIR LAWN, NJ, Feb 17, 2010 (MARKETWIRE via COMTEX News Network) -- Vyteris, Inc. (OTCBB: VYTR), developer of the first FDA-approved active transdermal drug delivery system and a leader in active transdermal drug delivery technology, announced today the appointment of Eugene A. Bauer, M.D. as Chairman of the company's Board of Directors. Dr. Bauer ...
|
|
Vyteris Announces Private Placement of $1.06 Million of Senior Subordinated Convertible Notes
Feb 8, 2010
|
9.2 KB |
|
| |
FAIR LAWN, NJ, Feb 08, 2010 (MARKETWIRE via COMTEX News Network) -- Vyteris, Inc. (OTCBB: VYTR), developer of the first FDA-approved active transdermal drug delivery system and a leader in active transdermal drug delivery technology, announced today the private placement of $1,060,000 of Senior Subordinated Convertible Promissory Notes due 2013.
...
|
|
|
= add release to Briefcase
|
